Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Buprenorphine (Opioid Dependance)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Buprenorphine 2mg sublingual tablets sugar free
0410030A0AAADAD
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 15,126 |
|
Buprenorphine 8mg sublingual tablets sugar free
0410030A0AAAEAE
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 14,583 |
|
Buprenorphine 2mg oral lyophilisates sugar free
0410030A0AAALAL
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 215 |
|
Buprenorphine 8mg oral lyophilisates sugar free
0410030A0AAAMAM
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 126 |
|
Buprenorphine 96mg/0.27ml prolonged-release inj pfs
0410030A0AAATAT
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 57 |
|
Buprenorphine 128mg/0.36ml prolonged-release inj pfs
0410030A0AAAUAU
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 55 |
|
Buprenorphine 64mg/0.18ml prolonged-release inj pfs
0410030A0AAASAS
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 22 |
|
Buprenorphine 160mg/0.45ml prolonged-release inj pfs
0410030A0AAAVAV
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 20 |
|
Buprenorphine 24mg/0.48ml prolonged-release inj pfs
0410030A0AAAQAQ
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 17 |
|
Buprenorphine 16mg/0.32ml prolonged-release inj pfs
0410030A0AAAPAP
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 8 |
|
Buprenorphine 8mg/0.16ml prolonged-release inj pfs
0410030A0AAANAN
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 6 |
|
Buprenorphine 32mg/0.64ml prolonged-release inj pfs
0410030A0AAARAR
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 3 |
|
Buprenorphine 1mg sublingual tablets sugar free
0410030A0AAAIAI
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 4mg sublingual tablets sugar free
0410030A0AAAKAK
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 6mg sublingual tablets sugar free
0410030A0AAAJAJ
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 74.2mg implant
0410030A0AAAWAW
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.